BA
CRKN

Bard Associates’s Crown Electrokinetics Corp. Common Stock CRKN Stock Holding History

Bard Associates’s Portfolio CRKN Stock Details CRKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$8.79K – 182
2023
Q3 		$8.79K Hold
1
– – ﹤0.01% 180
2023
Q2 		$164K Hold
1
– – 0.06% 165
2023
Q1 		$185K Hold
1
– – 0.08% 165
2022
Q4 		$244K Hold
1
– – 0.11% 150
2022
Q3 		$304K Buy
+1
New +$908K 0.14% 135

Other funds holding CRKN

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bard Associates's CRKN Position: Q4 2023 in Review

Bard Associates sold out of Crown Electrokinetics Corp. Common Stock (CRKN) in Q4 2023, closing a stake of 1 share — an estimated $8.79K sold.

Bard Associates first reported a position in CRKN in Q3 2022 and held it in 5 quarters. The position peaked at $304K in Q3 2022. 7 funds tracked by Wall St. Rank hold CRKN as of Q4 2023.

  • Bard Associates reported no remaining Crown Electrokinetics Corp. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Bard Associates sold 1 Crown Electrokinetics Corp. Common Stock share in Q4 2023, an estimated $8.79K.
  • Bard Associates first reported a position in Crown Electrokinetics Corp. Common Stock in Q3 2022 and held it in 5 quarters.
  • Bard Associates's Crown Electrokinetics Corp. Common Stock position peaked at $304K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Crown Electrokinetics Corp. Common Stock as of Q4 2023.

Based on Bard Associates's 13F filing for Q4 2023, filed 13 Feb 2024.